Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

St. Luke's Medical Center, City of Taguig

Baguio General Hospital and Medical Center, Baguio City

Wattanosoth Hospital, Bangkok

King Chulalongkorn Memorial Hospital, Bangkok

Rajavithi Hospital, Bangkok

Institute for Oncol & Radiol of Serbia, Clinic f. Med. Onco., Belgrade

Clinical Center of Serbia, Belgrade

National Cancer Institute, Cairo University, Cairo

Kasr Al Ainy Hospital, Cairo

Clinical Research Center, Alexandria University Hospital, Alexandria

Inst. for Pulm. Diseases of Vojvodine, Clinic f. Pulm. Oncol, Kamenitz

Clinical Center Kragujevac, Kragujevac

Nilai Medical Centre, Kampung Baharu Nilai

Songklanagarind Hospital, Songkhla

Sf. Nectarie Oncology Center, Craiova, Craiova

Regional Oncology Institute of Iasi, Medical Oncology, Iași

Braila County Emergency Hospital, Medical Oncology, Brăila

University Clinical Center, Gdansk, Gdansk

Specialist Hospital, Szczecin-Zdunowo, Szczecin-Zdunowo

Oncol Centre M Sklodowska-Curie, Dept of Lung & Chest Cancer, Warsaw

Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', Bucharest